临床生化检验指标在病毒性肝病患者诊断中的应用
2020-09-15吴艳鹏朱海燕
吴艳鹏 朱海燕

【摘 要】 目的:在对病毒性肝病患者进行临床诊断时生化检验指标的应用价值进行探讨。方法:选择我院病毒性肝炎患者45例为研究组,和同时期正常体检的健康志愿者40例为对照组进行研究,临床对全部受检者的血液样本,检验其生化指标,对病毒性肝病诊断过程中生化指标的应用价值进行分析。结果:研究组的TP、ALB、A/G水平、PA水平明显较低(P<0.05);且GLO水平、ALT、AST、ADA和LAP水平显著较高(P<0.05)。结论:临床上诊断病毒性肝病患者时应用生化检验指标,患者肝功能指标阳性率的变化显示更明显,加快了临床确诊和治疗的速度。
【关键词】 生化检验指标;病毒性肝病;诊断;应用
【中图分类号】 R197.6 【文献标志码】A 【文章编号】1005-0019(2020)17-020-01
Abstract:Objective:To explore the application value of biochemical indicators in clinical diagnosis of patients with viral liver disease. Methods:Forty-five patients with viral hepatitis in our hospital were selected as the research group, and 40 healthy volunteers with normal physical examination during the same period were selected as the control group. The blood samples of all subjects were clinically tested, and their biochemical indicators were tested for virality. The application value of biochemical indicators in the diagnosis of liver disease was analyzed. Results:The levels of TP, ALB, A / G, and PA in the study group were significantly lower (P <0.05); and the levels of GLO, ALT, AST, ADA, and LAP were significantly higher (P <0.05). Conclusion: The biochemical test indicators are used in clinical diagnosis of patients with viral liver disease, and the changes in the positive rate of patients' liver function indicators are more obvious, which accelerates the speed of clinical diagnosis and treatment.
Key words:Biochemical test index;Viral liver disease;diagnosis;application
病毒性肝病作為肝病中一种常见的分类,主要有急性、慢性和重度肝炎及肝硬化,对人们身体健康和生活质量有较大影响。近些年我国乙肝发病的概率在不断的上升,任何年龄段都有发病的可能。随着当前人们对肝病危害的认识越来越多,许多人也因此对携带肝病病毒者产生歧视,使其心理负担加重。而且假如不能及时准确的对病毒性肝病进行诊断和治疗,极易恶化为恶性肿瘤等,当前对病毒性肝病进行检查时血液生化检查的重要的一项。本文选择我院近两年接受的病毒性肝病患者,对其进行诊断时采用生化检验指标的价值进行了分析,进一步报道为:
1 资料与方法
1.1 一般资料 选择我院2017年11月—2019年12月收收治的病毒性肝炎患者45例为研究组,和同时期正常体检的健康志愿者40例为对照组。对照组男女比例为23:17;年龄最小为23岁,最大为74岁,均龄为(41.56±7.60)岁。研究组男女比例为21:24;年龄最小为21岁,最大为72岁,均龄为(39.68±6.57)岁;这些患者急慢性肝炎和肝硬化患者分别为37例、8例。……
